A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II-IV Epithelial Ovarian Cancer Following Negative Surgical Assessment

Author： Barakat R.R.   Almadrones L.   Venkatraman E.S.   Aghajanian C.   Brown C.   Shapiro F.   Curtin J.P.   Spriggs D.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.69, Iss.1, 1998-04, pp. : 17-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer

By Husain A.   Sabbatini P.   Spriggs D.   Fennelly D.   Aghajanian C.   Barakat R.   Curtin J.   Venkatraman E.   Hoskins W.   Markman M.  

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 96-101

Elsevier

Access to resources Recommend Favorite

Phase II Study of Intraperitoneal Cisplatin Plus Systemic Etoposide as Second-line Treatment in Patients With Small Volume Residual Ovarian Cancer

By de Jong R.S.   Willemse P.H.B.   Boonstra H.   de Vries E.G.E.   van der Graaf W.T.A.   Sleijfer D.T.   van der Zee A.G.J.   Mulder N.H.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 709-713

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

By Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 419-426

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up

By Morgan R.J.   Braly P.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Najera L.   Johnson D.   Doroshow J.H.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 433-438

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Gemcitabine plus Cisplatin Repeating Doublet Therapy in Previously Treated, Relapsed Ovarian Cancer Patients

By Nagourney R.A.   Brewer C.A.   Radecki S.   Kidder W.A.   Sommers B.L.   Evans S.S.   Minor D.R.   DiSaia P.J.  

Gynecologic Oncology, Vol. 88, Iss. 1, 2003-01 ,pp. : 35-39

Academic Press

Access to resources Recommend Favorite